Final Decision: HOLD

Reason: While the recent headlines suggest some negative sentiments around Divi's Labs, such as US supply worries and uncertainty over the US Biosecure Act, the company has downplayed the impact of Novartis losing an appeal in a US district court, and analysts' top picks include Divi's Labs, indicating a potential upside.